PROVIDER PROFILE · NPI 1699736686

Corey CutlerM.D.

Hematology-OncologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

123

Unique beneficiaries

—

Total services

262

Distinct HCPCS

Medicare payment

$21K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — bottom quintile (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

264

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

Brand share

62.9%

Top prescribed drugs

Ruxolitinib Phosphate85 claims

Belumosudil Mesylate49 claims

Atovaquone28 claims

Acyclovir22 claims

Sulfamethoxazole/Trimethoprim21 claims

QUALITY · MIPS · 2024

Final MIPS score

84.1

Quality

65.0

Cost

69.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.38%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$100K

Payment records

By payment type

Consulting Fee$59K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$36K

Travel and Lodging$4K

Food and Beverage$1K

REFERRAL NETWORK

Where Corey Cutler's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Francine Jacobson Diagnostic Radiology · Roanoke, VA	11	143
Rushdia Yusuf Hematology-Oncology · Boston, MA	11	253

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history